Sunshine Biopharma Inc (SBFM)
Sunshine Biopharma Inc (NASDAQ-SBFM) is a healthcare company in the biotechnology industry, and its listed security is NASDAQ common stock representing common equity. The company is associated with pharmaceutical research and development and with products sold through prescription and nonprescription channels. Its work is described in broad therapeutic terms that include oncology and antiviral areas, along with other medicine and supplement categories. As a publicly traded common equity security, SBFM reflects an ownership interest in the company rather than a separate fund, bond, or depositary receipt. Investors can use the NASDAQ listing and biotechnology classification to identify the security within the healthcare sector.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-SBFM
|
$1.42
|
56.5% Upside
|
Bargain
|
$56 6,079.0% Upside
|
Not available
|
Bargain
|
Fair
|
0.0%
|
November 10, 2026
|
0.1x
|
0.1x
|
3.514 M
|
-9.824 M
|
16.1%
|
98.2%
|
4.1
|
92.1%
|
